Concentra Q3 revenue +17% to $572.8M, EPS $0.38, raises FY2025 guidance

Concentra Group Holdings Parent, Inc.

2025-Q3 EPS reported $1.03 revenue$1,624,337,000

Revenue $572.8M (+17% YoY); net income $49.8M; EPS $0.38; adjusted EPS $0.39.
Adjusted EBITDA $118.9M (+17.1% YoY); visits per day +9.2%; revenue per visit $147.31 (+4.2%).
FY2025 guidance raised: revenue $2.145-2.160B, Adj. EBITDA $425-430M; net leverage target ≤3.5x.
Board declares $0.0625/share dividend payable Dec 9, 2025; authorizes $100M share repurchase program through Dec 2027.
Year-to-date revenue $1.624B (+13.2%); Adj. EBITDA $336.6M (+12.5%); total centers 628, onsite clinics 413.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.